|
|
|
|
|
by bildung
4460 days ago
|
|
> I see what you are aiming at, but the conclusion of clinical trials is almost never that simple. Yes, that's the problem with study subjects as complex as humans :) My academic background is in educational science and things are even fuzzier there: there never is a simple treatment->result relation because the persons receiving treatment reflect on that treatment, they are an active part in it. > In other words, it won't help laymen in the end. I think I know what you're meaning, but that's the point where I disagree: In my opinion this is no either/or situation but rather a question of relative amount of insight that can be given to laymen: Currently they will usually understand 0% of the scientific abstract. If we assume that a laymen's version of that abstract loses 80% of the information but is 100% understandable, that would still be a win. > Plus, you don't need that laymen language in the first place. Isn't that the job of journalists who cover scientific discoveries ? Absolutely, as journalists are already used to do exactly that. In practice the result will probably be exactly that: the institution will have science journalists who will produce these laymen's abstracts. |
|